Brief: Indaptus Therapeutics Announces FDA Clearance Of INDA To Initiate Phase 1 Clinical Trial Of DECOY20 In Solid Tumors
19/05/2022 12:02
May 19 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG
APPLICATION TO INITIATE PHASE 1 CLINICAL TRIAL OF DECOY20 IN SOLID TUMORS
Source text for Eikon: ID:nGNXbgJR40
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))